Skip to content

An intervention study to prevent sarcopenia in hospitalized patients

An intervention study to prevent sarcopenia in hospitalized patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs051190108
Enrollment
80
Registered
2020-02-18
Start date
2020-12-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 diabetes Type2 diabetes

Interventions

Arm A: take hard gummy three times daily for 1 week Arm B: take jelly three times daily for 1 week They also perform resistance exercise

Sponsors

Ikeda Kaori
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with type2 diabetes

Exclusion criteria

Exclusion criteria: Patients with type1 diabetes Steroid-treated patients Patients who received gastrectomy, pancreatectomy, or intestinal resection Patients who is difficult to be assessed muscle strength because of neuromuscular disease Somatostatin analog-treated patients Patients with hypothalamus or pituitary disease Patients who restrict protein intake because of kidney disease Patients who have difficulty of food intake or ingestion Patients with dementia Patients who restrict exercise Patients whose ADL (Activity of Daily Living) is weakened Unsuitable patients

Design outcomes

Primary

MeasureTime frame
Decline of muscle mass during hospitalization

Secondary

MeasureTime frame
Body composition, physical performance, chewing ability, attentional control, anabolic hormones for muscle growth, the change of blood glucose and glucose metabolic hormone, the change of amino acids fractionation, the change of lactate

Contacts

Public ContactEmi Okamura

Kyoto University Hospital

e_okamura@kuhp.kyoto-u.ac.jp+81-75-751-3560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026